People who trust pharma are more interested in using the industry’s services – making building confidence in the sector key to realising the potential of patient centricity.
The rise in the use of decentralised clinical trial (DCTs) designs forced by COVID-19 looks set to outlast the pandemic, and digital health company Seqster has formed another partnership to